Institute of HIV Research and Innovation and Center of Excellence in Transgender Health, Chulalongkorn University, Bangkok, Thailand.
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, United States of America.
PLoS One. 2022 Jan 21;17(1):e0262694. doi: 10.1371/journal.pone.0262694. eCollection 2022.
To reach its goal of ending AIDS by 2030, Thailand has adopted antiretroviral treatment as prevention and HIV pre-exposure prophylaxis for men who have sex with men (MSM) and transgender women (TGW) as its core HIV control strategy. However, in the absence of reliable epidemiologic indicators, the impact of these policies on the course of the HIV epidemic in these groups remains unknown. To help answer this question, we formulated an HIV epidemic consensus initiative for Bangkok, Thailand, to analyze epidemiologic and program data and reach agreement between experts and stakeholders on the evolving state of the HIV epidemic among MSM and TGW. A customized Delphi process was used to consult and consolidate viewpoints of experts and stakeholders. Experts presented and discussed HIV prevalence and incidence data from recent and ongoing studies among MSM and TGW in Bangkok (2014 to 2018) during a meeting with stakeholders representing government, donors, and civil society. Agreement about the course of the HIV epidemic among MSM and TGW was attained by voting consensus. Based on presented data, meeting participants agreed that HIV prevalence and incidence had decreased among Bangkok MSM from 2014 to 2018. Despite these declines, HIV prevalence and incidence were found to remain high. This was particularly the case among younger MSM. Participants agreed that there was no evidence for a decrease in HIV prevalence and incidence among Bangkok TGW. Introduction of antiretroviral treatment as prevention and HIV pre-exposure prophylaxis may have contributed to these declines. However, HIV prevalence and incidence remained high, and no signs of a decrease were reported among Bangkok TGW. At the current rate of new HIV infections in MSM and TGW, Thailand will not reach its goal of ending AIDS by 2030. This HIV consensus initiative may serve as a model for building agreement and advocacy on epidemiologic and program data and their implications for a large metropolitan city.
为实现到 2030 年终结艾滋病的目标,泰国将艾滋病抗病毒治疗作为预防措施,并将男男性行为者和跨性别女性中的艾滋病毒暴露前预防措施作为核心艾滋病毒控制战略。然而,由于缺乏可靠的流行病学指标,这些政策对这些人群中艾滋病毒流行进程的影响仍不得而知。为帮助回答这一问题,我们为泰国曼谷制定了艾滋病毒流行共识倡议,以分析流行病学和规划数据,并在专家和利益攸关方之间就男男性行为者和跨性别女性中的艾滋病毒流行状况的演变达成一致意见。采用定制的德尔菲法,向代表政府、捐助方和民间社会的利益攸关方咨询并整合专家的观点。专家在与利益攸关方的会议上介绍和讨论了曼谷最近和正在进行的男男性行为者和跨性别女性中的艾滋病毒流行率和发病率研究(2014 至 2018 年)的数据。通过投票共识达成了关于男男性行为者和跨性别女性中的艾滋病毒流行进程的一致意见。根据介绍的数据,与会者同意,从 2014 年至 2018 年,曼谷男男性行为者中的艾滋病毒流行率和发病率有所下降。尽管有所下降,但艾滋病毒流行率和发病率仍居高不下。在较年轻的男男性行为者中尤其如此。与会者一致认为,曼谷跨性别女性中的艾滋病毒流行率和发病率没有下降的证据。艾滋病抗病毒治疗作为预防措施和艾滋病毒暴露前预防措施的推出可能促成了这些下降。然而,艾滋病毒流行率和发病率仍然很高,曼谷跨性别女性中没有报告减少的迹象。按照目前男男性行为者和跨性别女性中的新艾滋病毒感染率,泰国将无法实现到 2030 年终结艾滋病的目标。这项艾滋病毒共识倡议可作为就流行病学和规划数据及其对大都市区的影响达成一致意见和进行宣传的模式。
Cochrane Database Syst Rev. 2008-7-16
Cochrane Database Syst Rev. 2011-9-7
Health Technol Assess. 2001
Cochrane Database Syst Rev. 2010-3-17
JMIR Public Health Surveill. 2024-12-6
N Engl J Med. 2021-8-12